Loading Complete
Una D. McCann

Una D. McCann, MD

Psychiatry

Johns Hopkins Affiliations:
  • Johns Hopkins School of Medicine Faculty

Languages

  • Spanish
  • English

14 Insurances Accepted

View all

Gender

Female

About Una D. McCann

Professional Titles

  • Associate Program Director JHBMC GCRC
  • Director, Anxiety Disorders Program

Primary Academic Title

Professor of Psychiatry and Behavioral Sciences

Background

Dr. Una McCann is a psychiatric specialist in Baltimore, caring for patients with anxiety disorders, obsessive-compulsive disorders and post-traumatic stress. Dr. McCann serves as Associate Program Director at the Johns Hopkins Bayview Medical Center Graduate Clinical Research Center. She is also Director of the Anxiety Disorders Program and Co-Director of the Center for Interdisciplinary Sleep Medicine and Research at Johns Hopkins School of Medicine.

Dr. McCann received her undergraduate degree in psychology from Princeton University. She earned her M.D. from Duke University School of Medicine. She completed her residency at Stanford University School of Medicine, where she also performed a fellowship in psychiatry. Dr. McCann joined the Johns Hopkins faculty in 1999.

Her research interests include amphetamine-induced monoamine neurotoxicity and the neurobiology of anxiety disorders.

Dr. McCann is a member of the Society for Neuroscience. She speaks both English and Spanish.

Additional Academic Titles

Professor of Neurology

Research Interests

Amphetamine-induced Monoamine Neurotoxicity, Neurobiology of Anxiety Disorders

Core Facility

Interdisciplinary Sleep, Research and Education (CISRE), Center for

Research Summary

Dr. McCann’s two active areas of research are in amphetamine-induced monoamine neurotoxicity (i.e., MDMA, methamphetamine, ephedrine or amphetamine-induced monoaminergic neurotoxicity) and the neurobiology of anxiety disorders. Methods used in both research spheres include neuropharmacology, PET, MRI, fMRI, polysomnography, pharmacological challenge and neuropsychiatric assessment. Studies of amphetamine neurotoxicity also include preclinical studies using microarrays, cell culture, rodents and primates.

Selected Publications

  • Garg A, Kapoor S, Goel M, Chopra S, Chopra M, Kapoor A, McCann UD, Behera C. “Functional Magnetic Resonance Imaging in Abstinent MDMA Users: A Review.” Curr Drug Abuse Rev. 2015;8(1):15-25

  • Mueller M, Maldonado-Adrian C, Yuan J, McCann UD, Ricaurte GA. “Studies of (±) 3,4-methylenedioxymethamphetamine (MDMA) metabolism and disposition in rats and mice: relationship to neuroprotection and neurotoxicity profile.” J Pharmacol Exp Ther. 2013 Feb;344(2):479-88

  • Mueller M, Yuan J, McCann UD, Hatzidimitriou G, Ricaurte GA. “Single oral doses of (±) 3,4-methylenedioxymethamphetamine ('Ecstasy') produce lasting serotonergic deficits in non-human primates: relationship to plasma drug and metabolite concentrations.” Int J Neuropsychopharmacol. 2013 May;16(4):791-801

  • Rao V, Mielke M, Xu X, Smith GS, McCann UD, Bergey A, Doshi V, Pham DL, Yousem D, Mori S. “Diffusion tensor imaging atlas-based analyses in major depression after mild traumatic brain injury.” J Neuropsychiatry Clin Neurosci. 2012 Summer;24(3):309-15

  • Williams MS, Ziegelstein RC, McCann UD, Gould NF, Ashvetiya T, Vaidya D. “Platelet Serotonin Signaling in Patients With Cardiovascular Disease and Comorbid Depression.” Psychosom Med. 2019 May;81(4):352-362

Courses & Syllabi

  • Cognitive Behavior Therapy Training, Psychiatry PGY-III, 1/1/04
  • Anxiety Disorders Seminar, 1/1/04
  • Psychiatry PGY-III Lecture Series, 1/1/04
  • Medical Students Psychiatry Rotation, 1/1/04
  • GIM Psychiatry Lecture Series, 1/1/02
  • Introduction to Clinical Research Practicum, 1/1/02 - 1/1/03
  • Introduction to Clinical Research Course, 1/1/01 - 1/1/03

Honors

  • U.S. Army Commissioned Officers Award, 1/1/95
  • Moos Fellowship for Clinical Research in Psychiatry, Stanford University, 1/1/87
  • Sigma Xi Award in Psychology, 1/1/80
  • Howard Hughes Foundation Student Scholar, Peter Bent Brigham Hospital, 1/1/80
  • Phi Beta Kappa and Sigma Xi Societies, 1/1/80

Memberships

  • Society for Neuroscience

Professional Activities

  • Addiciones, Editorial board member
  • Journal of Addiction, Editorial board member
  • Journal of Sleep Disorders: Treatment and Care, Editorial board member
  • Journal of Women's Health and Gender Based Medicine, Editorial board member
  • Psychotherapy and Psychological Disorders, Editorial board member
  • WebmedCentral Plus, Editorial board member
  • Women in Medicine, Editorial board member

Expertise

Education

Stanford University Medicine

Fellowship, Psychiatry, 1988

Stanford University Medicine

Residency, Psychiatry, 1988

Duke University School of Medicine

Medical Education, MD, 1984

Board Certifications

Psychiatry

American Board of Psychiatry and Neurology, 1990

Insurance

Johns Hopkins providers accept various commercial health insurance plans. However, they may not be included in all of an insurance company's plans or offerings. This may include Exchange, Medicaid, Medicare, and specific limited benefit plans. Exceptions to participation also exist based on your employer’s benefits package and the provider's location or specialty. Please contact your insurer directly to make sure your doctor is covered by your plan. For more details, please review our Insurance Information.
Search plans
  • Aetna
  • CareFirst
  • Cigna
  • First Health
  • Geisinger Health Plan
  • HealthSmart/Accel
  • Humana
  • Johns Hopkins Health Plans
  • MultiPlan
  • Pennsylvania's Preferred Health Networks (PPHN)
  • Point Comfort Underwriters
  • Private Healthcare Systems (PHCS)
  • UnitedHealthcare
  • Veteran Affairs Community Care Network (Optum-VACCN)